Standout Papers
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (2010)
- The orphan receptor GPR55 is a novel cannabinoid receptor (2007)
- Why do
SGLT2 inhibitors reduce heart failure hospitalization?A differential volume regulation hypothesis (2017)
Immediate Impact
26 by Nobel laureates 27 from Science/Nature 74 standout
Citing Papers
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
2023 Standout
Works of Peter J. Greasley being referenced
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
2020
Mutational and Computational Analysis of the α1b-Adrenergic Receptor
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter J. Greasley | 1559 | 1502 | 400 | 2786 | 109 | 5.7k | |
| Michael Davidson | 2396 | 887 | 76 | 1004 | 117 | 6.8k | |
| Jean‐Pierre Maffrand | 557 | 1588 | 42 | 1257 | 90 | 5.8k | |
| Henrik H. Hansen | 749 | 1769 | 31 | 1139 | 106 | 4.6k | |
| Francesco Rossi | 766 | 2067 | 59 | 1237 | 190 | 7.7k | |
| Jonathan Z. Long | 992 | 3626 | 44 | 4182 | 93 | 12.1k | |
| Simon D Harding | 448 | 2915 | 110 | 764 | 36 | 6.8k | |
| C. Robin Hiley | 397 | 1559 | 31 | 1461 | 102 | 4.5k | |
| D. R. Abernethy | 555 | 2961 | 46 | 890 | 36 | 6.9k | |
| Brian C. Callaghan | 1409 | 1277 | 75 | 582 | 176 | 8.0k | |
| Robert C. Speth | 2190 | 2986 | 80 | 846 | 216 | 7.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...